Search details
1.
Enantioselective synthesis of 4-aryl-3,4-dihydrocoumarins via N-heterocyclic carbene catalyzed ß-arylation/cyclization of α-bromoenals.
Org Biomol Chem
; 22(25): 5101-5104, 2024 Jun 26.
Article
in English
| MEDLINE | ID: mdl-38859801
2.
Concurrent chemoradiotherapy followed by adjuvant cisplatin-gemcitabine versus cisplatin-fluorouracil chemotherapy for N2-3 nasopharyngeal carcinoma: a multicentre, open-label, randomised, controlled, phase 3 trial.
Lancet Oncol
; 24(7): 798-810, 2023 07.
Article
in English
| MEDLINE | ID: mdl-37290468
3.
Deep learning signatures reveal multiscale intratumor heterogeneity associated with biological functions and survival in recurrent nasopharyngeal carcinoma.
Eur J Nucl Med Mol Imaging
; 49(8): 2972-2982, 2022 07.
Article
in English
| MEDLINE | ID: mdl-35471254
4.
Prognostic significance of AKR1C4 and the advantage of combining EBV DNA to stratify patients at high risk of locoregional recurrence of nasopharyngeal carcinoma.
BMC Cancer
; 22(1): 880, 2022 Aug 11.
Article
in English
| MEDLINE | ID: mdl-35953777
5.
Determining the suitability of definitive radiation therapy in patients with metastatic nasopharyngeal carcinoma based on PET/CT: a large cohort study.
Eur Radiol
; 32(11): 7722-7732, 2022 Nov.
Article
in English
| MEDLINE | ID: mdl-35505116
6.
Nomogram for the prediction of primary distant metastasis of nasopharyngeal carcinoma to guide individualized application of FDG PET/CT.
Eur J Nucl Med Mol Imaging
; 48(8): 2586-2598, 2021 07.
Article
in English
| MEDLINE | ID: mdl-33420610
7.
Percent change in apparent diffusion coefficient and plasma EBV DNA after induction chemotherapy identifies distinct prognostic response phenotypes in advanced nasopharyngeal carcinoma.
BMC Cancer
; 21(1): 1320, 2021 Dec 09.
Article
in English
| MEDLINE | ID: mdl-34886807
8.
Low value of whole-body dual-modality [18f]fluorodeoxyglucose positron emission tomography/computed tomography in primary staging of stage I-II nasopharyngeal carcinoma: a nest case-control study.
Eur Radiol
; 31(7): 5222-5233, 2021 Jul.
Article
in English
| MEDLINE | ID: mdl-33416977
9.
Comparing three induction chemotherapy regimens for patients with locoregionally advanced nasopharyngeal carcinoma based on TNM stage and plasma Epstein-Barr virus DNA level.
BMC Cancer
; 20(1): 89, 2020 Feb 03.
Article
in English
| MEDLINE | ID: mdl-32013967
10.
Maximal standard uptake values of 18F-fluoro-2-deoxy-D-glucose positron emission tomography compared with Epstein-Barr virus DNA as prognostic indicators in de novo metastatic nasopharyngeal carcinoma patients.
BMC Cancer
; 19(1): 908, 2019 Sep 11.
Article
in English
| MEDLINE | ID: mdl-31511059
11.
Identifying optimal candidates for local treatment of the primary tumor among patients with de novo metastatic nasopharyngeal carcinoma: a retrospective cohort study based on Epstein-Barr virus DNA level and tumor response to palliative chemotherapy.
BMC Cancer
; 19(1): 92, 2019 Jan 21.
Article
in English
| MEDLINE | ID: mdl-30665378
12.
Neoadjuvant or Adjuvant Chemotherapy Plus Concurrent CRT Versus Concurrent CRT Alone in the Treatment of Nasopharyngeal Carcinoma: A Study Based on EBV DNA.
J Natl Compr Canc Netw
; 17(6): 703-710, 2019 06 01.
Article
in English
| MEDLINE | ID: mdl-31200353
13.
Concurrent chemoradiotherapy with nedaplatin versus cisplatin in stage II-IVB nasopharyngeal carcinoma: an open-label, non-inferiority, randomised phase 3 trial.
Lancet Oncol
; 19(4): 461-473, 2018 04.
Article
in English
| MEDLINE | ID: mdl-29501366
14.
Symptomatic venous thromboembolism associated with peripherally inserted central catheters predicts a worse survival in nasopharyngeal carcinoma: results of a large cohort, propensity score-matched analysis.
BMC Cancer
; 18(1): 1297, 2018 Dec 29.
Article
in English
| MEDLINE | ID: mdl-30594171
15.
Liposomal paclitaxel versus docetaxel in induction chemotherapy using Taxanes, cisplatin and 5-fluorouracil for locally advanced nasopharyngeal carcinoma.
BMC Cancer
; 18(1): 1279, 2018 Dec 20.
Article
in English
| MEDLINE | ID: mdl-30572856
16.
Genetic Associations of Primary Angle-Closure Disease: A Systematic Review and Meta-Analysis.
JAMA Ophthalmol
; 142(5): 437-444, 2024 May 01.
Article
in English
| MEDLINE | ID: mdl-38546604
17.
A phase II randomised controlled trial of adjuvant tumour-infiltrating lymphocytes for pretreatment Epstein-Barr virus DNA-selected high-risk nasopharyngeal carcinoma patients.
Eur J Cancer
; 191: 112965, 2023 09.
Article
in English
| MEDLINE | ID: mdl-37540921
18.
Reduced-dose radiotherapy for Epstein-Barr virus DNA selected staged III nasopharyngeal carcinoma: A single-arm, phase 2 trial.
Eur J Cancer
; 194: 113336, 2023 11.
Article
in English
| MEDLINE | ID: mdl-37801967
19.
Association of Treatment Advances With Survival Rates in Pediatric Patients With Nasopharyngeal Carcinoma in China, 1989-2020.
JAMA Netw Open
; 5(3): e220173, 2022 Mar 01.
Article
in English
| MEDLINE | ID: mdl-35234882
20.
The Prognostic Role of Plasma Epstein-Barr Virus DNA Levels in the Middle of Intensity Modulated Radiation Therapy to Guide Cisplatin Dose Recommendation in Concurrent Chemoradiation Therapy in Patients With Locally Advanced Nasopharyngeal Carcinoma: A Large Cohort Study.
Adv Radiat Oncol
; 7(3): 100908, 2022.
Article
in English
| MEDLINE | ID: mdl-35647403